16 completed, 2 terminated, 2 unknown, 2 withdrawn. 8 Phase 3, 7 Phase 2, 4 Not applicable, 2 Phase 1, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 6, Terminated 1, Withdrawn 1 |
| Phase 2 | 7 | Completed 6, Terminated 1 |
| Not applicable | 4 | Completed 2, Unknown 2 |
| Phase 1 | 2 | Completed 2 |
| Early Phase 1 | 1 | Withdrawn 1 |
Follow Molluscum Contagiosum: new trials by email Literature Review of Molluscum Contagiosum trials Research Report on Molluscum Contagiosum
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cold Atmospheric Plasma Device Extension Study Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP) - Verruca Vulgaris, Molluscum Contagiosum | Phase 3 | Terminated | Medical University of South Carolina | 60 | 2023-09-18 | 2026-04-03 |
| Study of a Cohort of Children With Molluscum Contagiosum (MC) Treated With a 5% Solution of Potassium Hydroxide (Molutrex®) Applied Locally to the Skin Molluscum Contagiosum | Completed | Laboratoire Dermatologique ACM | 109 | 2023-01-20 | 2024-05-29 | |
| Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in Molluscum Contagiosum Group A received cryotherpay, Group B received 10% Potassium Hydroxide Solution - Molluscum Contagiosum | Phase 1 | Completed | Combined Military Hospital Abbottabad | 60 | 2022-11-01 | 2023-06-09 |
| MC RCT - BPO vs Adapalene Benzoyl peroxide, Adapalene Gel - Molluscum Contagiosum | Phase 3 | Withdrawn | University of Oklahoma | 2022-05-18 | 2024-03-06 | |
| Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in Treatment of Molluscum Contagiosum potassium hydroxide - Molluscum Contagiosum | Phase 1 | Completed | Combined Military Hospital Abbottabad | 60 | 2022-03-01 | 2022-12-02 |
| A Phase 3 Molluscum Contagiosum Efficacy and Safety Study SB206 10.3% berdazimer, vehicle gel - Molluscum Contagiosum | Phase 3 | Completed | Novan, Inc. | 891 | 2020-09-01 | 2023-01-26 |
| The Effectiveness of Oral Acyclovir in the Treatment of Molluscum Contagiosum in Children Acyclovir, KOH 10 % - Molluscum Contagiosum | Not applicable | Unknown | Dalia Mahran | 35 | 2020-06-15 | 2020-07-20 |
| A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MC SB206 12%, Placebo - Molluscum Contagiosum | Phase 3 | Completed | Novan, Inc. | 355 | 2019-06-13 | 2023-03-23 |
| A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1) SB206 12%, Placebo - Molluscum Contagiosum | Phase 3 | Completed | Novan, Inc. | 352 | 2019-06-03 | 2022-12-27 |
| Cantharidin Application in Molluscum Patients-1 VP-102 - Cantharidin, Topical Film Forming Solution, Placebo -Topical Film Forming Solution without VP-102 - Molluscum Contagiosum | Phase 3 | Completed | Verrica Pharmaceuticals Inc. | 266 | 2018-03-21 | 2022-01-11 |
| Cantharidin Application in Molluscum Patients VP-102 - Cantharidin, Topical Film Forming Solution, Placebo -Topical Film Forming Solution without VP-102 - Molluscum Contagiosum | Phase 3 | Completed | Verrica Pharmaceuticals Inc. | 262 | 2018-02-14 | 2021-12-14 |
| A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum SB206 4%, SB206 8%, SB206 12% - Molluscum Contagiosum | Phase 2 | Completed | Novan, Inc. | 256 | 2018-01-24 | 2023-05-06 |
| Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients Picato - Molluscum Contagiosum | Early Phase 1 | Withdrawn | Center for Clinical Studies, Texas | 2017-12-20 | 2022-04-01 | |
| Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum. VP-102 with applicator - Molluscum Contagiosum | Phase 2 | Completed | Verrica Pharmaceuticals Inc. | 33 | 2017-06-08 | 2021-08-11 |
| A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum VBP-245 Topical Gel, Vehicle - Molluscum Contagiosum | Phase 2 | Completed | Veloce BioPharma LLC | 110 | 2017-02-27 | 2018-10-11 |
| Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo Screening, Tele-dermatology - Erysipelas, Impetigo | Not applicable | Completed | Centro Studi Gised | 461 | 2016-10-01 | 2019-05-17 |
| Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2 Cantharidin - Molluscum Contagiosum | Phase 2 | Completed | Steven R Cohen | 30 | 2016-09-01 | 2019-01-30 |
| A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum 10% East Indian sandalwood oil cream, Placebo Cream - Molluscum Contagiosum | Phase 2 | Terminated | ViroXis Corporation | 27 | 2016-02-01 | 2019-04-16 |
| Using a Cold Atmospheric Plasma Device to Treat Skin Disorders Non-thermal, atmospheric plasma to treat skin lesions and acne, Indirect non-thermal, atmospheric plasma to treat hair loss and acne - Actinic Keratosis, Acne/Rosacea | Not applicable | Unknown | The Skin Center Dermatology Group | 100 | 2016-01-01 | 2022-04-12 |
| Safety and Efficacy Study of Topical Cantharidin for the Treatment of Molluscum Contagiosum Cantharidin, Placebo, Gauze occlusion bandage - Molluscum Contagiosum | Phase 2 | Completed | Montefiore Medical Center | 94 | 2012-07-01 | 2017-05-05 |
Showing 20 of 22. Sign in to see all of them.
Skin Diseases (3) · Skin Diseases, Viral (3) · Warts (3) · Cellulitis (2) · Keratosis, Actinic (2) · Poxviridae Infections (2) · Tinea (2) · Alzheimer Disease (1) · Bowen's Disease (1) · Carcinoma, Basal Cell (1) · Carcinoma, Squamous Cell (1) · Erysipelas (1) · Herpes Zoster (1) · Impetigo (1)
DNA Virus Infections (22) · Infections (22) · Skin Diseases, Infectious (22) · Skin and Connective Tissue Diseases (22) · Virus Diseases (22) · Poxviridae Infections (20) · Skin Diseases (19) · Skin Diseases, Viral (19) · Papillomavirus Infections (3) · Tumor Virus Infections (3) · Bacterial Infections and Mycoses (2) · Carcinoma (2) · Connective Tissue Diseases (2) · Dermatomycoses (2) · Inflammation (2)
berdazimer sodium (4) · VP-102 (3) · Cantharidin (2) · potassium hydroxide (2) · 3-ingenyl angelate (1) · Acyclovir (1) · Benzoyl Peroxide (1) · Mass Screening (1)
Novan, Inc. (4) · Verrica Pharmaceuticals Inc. (3) · Combined Military Hospital Abbottabad (2) · Center for Clinical Studies, Texas (1) · Centro Studi Gised (1) · Dalia Mahran (1) · Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (1) · Laboratoire Dermatologique ACM (1) · Medical University of South Carolina (1) · Montefiore Medical Center (1) · Steven R Cohen (1) · The Skin Center Dermatology Group (1) · University of North Carolina, Chapel Hill (1) · University of Oklahoma (1) · Veloce BioPharma LLC (1)
United States (15) · Pakistan (2) · Egypt (1) · France (1) · Italy (1) · Spain (1)
Lawrence Eichenfield, MD (2) · Adelaide Hebert, MD (1) · Amy Paller, MD (1) · Bushra Muzaffar, FCPS (1) · Gary Goldenberg, MD (1) · Ghada Mahmoud, Assist Prof (1) · Jacquelyn R Dosal, MD (1) · Jason Hirshburg, MD (1) · Jayashri Krishnan, PhD (1) · John C. Browning, MD FAAD FAAP (1) · Luigi Naldi, MD (1) · Stephen K Tyring, MD, PhD (1) · Steven R Cohen, MD, MPH (1) · Tomoko Maeda Chubachi, MD PhD (1)
PMID 32965495, PMID 33599960, PMID 34909721, PMID 34976290, PMID 22011376, PMID 33400412, PMID 35491738, PMID 35830173, PMID 36287306, PMID 36302167